MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment

    R. Scherbaum, E. Hinrichs, A. Horstmann, J. Schmidt-Fleischer, J. Stein, J. Geritz, J. Welzel, E. Kwon, J. Oppermann, V. Tschentscher, A. Mattukat, S. Muhlack, S. Faissner, C. Hansen, K. Winklhofer, R. Gold, W. Maetzler, N. Timmesfeld, L. Tönges (Bochum, Germany)

    Objective: To describe (1) the real-world effectiveness of the multidisciplinary inpatient rehabilitation (MIR) ‘Parkinson’s Disease Multimodal Complex Treatment’ (PD-MCT) in people with PD (PwP) compared…
  • 2024 International Congress

    Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

    S. Govender, S. Haffejee (Johannesburg, South Africa)

    Objective: To provide evidence-based services for patients with Parkinson’s disease considering the burden of disease in South Africa (SA) and access, socio economic and technology…
  • 2024 International Congress

    Quality of Life in Parkinson’s Disease Patients with Sleep Disturbances

    C. Falup-Pecurariu, L. Ungureanu, R. Filip, I. Murasan, B. Opritoiu, A. Zarnoveanu, S. Diaconu (Brasov, Romania)

    Objective: to evaluate the quality of life of Parkinson’s disease (PD) patients with sleep disturbances. Background: Sleep disturbances are one of the most frequent non…
  • 2024 International Congress

    Health Care Utilization at the End-Of-Life in Parkinson´s Disease

    B. Leavy, E. åkesson, J. Lökk, T. Schultz, P. Strang, E. Franzén (Stockholm, Sweden)

    Objective: This study aims to increase knowledge concerning end of life health care utilization among an urban-dwelling Parkinson's disease (PD) cohort. More specifically we investigated frequency…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 2024 International Congress

    Clinical and Neurophysiological Response of Different Protocols of Non-Invasive Spinal Neuromodulation in Anti-Gad Positive Stiff Person Syndrome: A Case Report

    V. Maciel, G. Silva, R. Carra, J. Baima, J. Oliveira, M. Silva, P. Lacerda, K. Massruha, C. Heise, C. Tanaka, R. Cury (São Paulo, Brazil)

    Objective: To evaluate the effects of non-invasive neuromodulation techniques transpinal magnetic stimulation (TsMS) and transcutaneous electrical stimulation (TENS) in Stiff person syndrome (SPS). Background: SPS…
  • 2024 International Congress

    Common and specific immediate effects in brain oscillations and motor symptoms of tDCS and tACS in Parkinson’s disease: A randomized controlled trial

    JJ. Bu, JF. Liu, H. Wan, C. Jin (Hefei, China)

    Objective: We conducted the first randomized controlled trial (RCT) to compare the modulation of Parkinson's disease (PD) patients by tDCS and tACS. Background: PD entails…
  • 2024 International Congress

    Comparing digital gait and turning measures from a prescribed gait test in the clinic/laboratory versus the same test at home in people with Parkinson’s disease

    V. Shah, C. Silva-Batista, P. Burgos, A. Ragothaman, P. Carlson-Kuhta, K. Sowalsky, F. Horak, M. Mancini (Portland, USA)

    Objective: We aim to compare the performance of the same prescribed walk test in the laboratory/clinic versus in the home. Background: With the advent of…
  • 2024 International Congress

    Research Information Disclosure In The PPMI Study: Development Of A Disclosure Process

    T. Tropea, J. Schulze, C. Destro, L. Heathers, B. Henry, JM. Talarico, C. Stanley, M. Mcguire Kuhl, E. Flagg, T. Foroud (Philadelphia, USA)

    Objective: The Parkinson Progression Markers Initiative (PPMI) is a multinational, longitudinal observational study that collects clinical, imaging, biologic, and genetic data from participants with or…
  • 2024 International Congress

    Identifying Subjects with Dopamine Transporter Deficit in a Population-based Recruitment Strategy: Kassel Data of Healthy Brain Ageing

    S. Schade, K. Rege, C. Corinne, A. Garrido, T. Marques, P. Mahlknecht, S. Ghosh, R. Rawal, C. Pauly, T. Wicke, E. Lang, S. Schnell, S. Scaglione, H. Hakelberg, V. Satagopam, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer, D. Pilco (Kassel, Germany)

    Objective: To identify subjects with dopamine transporter (DaT) deficit being at high risk for prodromal PD. Background: Neurodegeneration and dopaminergic deficit in PD occur before the development…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley